tiprankstipranks
Cynata Therapeutics Limited (CYYNF)
:CYYNF
US Market

Cynata Therapeutics Limited (CYYNF) Financial Statements

Compare
4 Followers

Cynata Therapeutics Limited Financial Overview

Cynata Therapeutics Limited's market cap is currently $34.67M. The company's EPS TTM is $-0.035; its P/E ratio is ―; Cynata Therapeutics Limited is scheduled to report earnings on February 20, 2025, and the estimated EPS forecast is $―. See an overview of income statement, balance sheet, and cash flow financials.
Jun 24Jun 23Jun 22Jun 21Jun 20
Income Statement
Total RevenueAU$ 2.32MAU$ 1.65MAU$ 7.77MAU$ 1.55MAU$ 7.01M
Gross ProfitAU$ 2.32MAU$ 1.37MAU$ 7.49MAU$ 1.27MAU$ 6.73M
Operating IncomeAU$ -8.81MAU$ -16.54MAU$ -6.90MAU$ -9.08MAU$ -10.51M
EBITDAAU$ -9.95MAU$ -15.65MAU$ -6.00MAU$ -8.80MAU$ -5.87M
Net IncomeAU$ -9.74MAU$ -14.28MAU$ -5.45MAU$ -7.69MAU$ -3.64M
Balance Sheet
Cash & Short-Term InvestmentsAU$ 6.21MAU$ 16.17MAU$ 23.80MAU$ 26.72MAU$ 13.65M
Total AssetsAU$ 8.39MAU$ 18.99MAU$ 26.55MAU$ 29.97MAU$ 17.48M
Total DebtAU$ 0.00AU$ 0.00AU$ 0.00AU$ 0.00AU$ 0.00
Net DebtAU$ -6.21MAU$ -16.17MAU$ -23.80MAU$ -26.72MAU$ -13.65M
Total LiabilitiesAU$ 1.17MAU$ 2.26MAU$ 2.59MAU$ 1.60MAU$ 689.74K
Stockholders' EquityAU$ 7.22MAU$ 16.73MAU$ 23.96MAU$ 28.37MAU$ 16.79M
Cash Flow
Free Cash FlowAU$ -9.96MAU$ -14.28MAU$ -3.30MAU$ -5.16MAU$ -3.39M
Operating Cash FlowAU$ -9.96MAU$ -14.28MAU$ -3.30MAU$ -5.16MAU$ -3.39M
Investing Cash FlowAU$ 0.00AU$ 0.00AU$ 0.00AU$ 0.00AU$ 0.00
Financing Cash FlowAU$ 0.00AU$ 6.72MAU$ 210.12KAU$ 18.20MAU$ 10.06M
Currency in AUD

Cynata Therapeutics Limited Earnings and Revenue History

Cynata Therapeutics Limited Debt to Assets

Cynata Therapeutics Limited Cash Flow

Cynata Therapeutics Limited Forecast EPS vs Actual EPS

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis